| __timestamp | Alpine Immune Sciences, Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 7459000 |
| Thursday, January 1, 2015 | 16054000 | 11831000 |
| Friday, January 1, 2016 | 23316000 | 25705000 |
| Sunday, January 1, 2017 | 10626000 | 46181000 |
| Monday, January 1, 2018 | 28970000 | 59497000 |
| Tuesday, January 1, 2019 | 35847000 | 65003000 |
| Wednesday, January 1, 2020 | 27185000 | 74506000 |
| Friday, January 1, 2021 | 58742000 | 126006000 |
| Saturday, January 1, 2022 | 70243000 | 126215000 |
| Sunday, January 1, 2023 | 80904000 | 120161000 |
Data in motion
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and Protagonist Therapeutics, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, Alpine Immune Sciences increased its R&D expenses by over 560%, peaking in 2023. Meanwhile, Protagonist Therapeutics saw a remarkable 1,510% rise, with its highest spending in 2022. Notably, Protagonist consistently outspent Alpine, with 2021 marking a year where Protagonist's R&D expenses were nearly double those of Alpine.
This trend underscores the fierce competition and the relentless pursuit of breakthroughs in the biotech sector, where strategic R&D investments can lead to groundbreaking therapies and substantial market advantages.
R&D Insights: How Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Exelixis, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Novavax, Inc.
Research and Development Expenses Breakdown: Veracyte, Inc. vs Protagonist Therapeutics, Inc.
Research and Development Investment: Protagonist Therapeutics, Inc. vs Evotec SE